Amundi Asset Management ... Stock Quote CI1 - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
ETFs
Italy
BIT
Amundi Asset Management SAS (CI1) Quote

Amundi Asset Management SAS (CI1)

0.00

0.00

( 0.00% )

Updated: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

-

Bid

-

Ask

-

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

-

Open

-

Last Trade

Last Trade Time

-

Average Volume (3m)

-

Financial Volume

-

VWAP

-

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update

FLORHAM PARK, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and...

Form 8-K - Current report

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

FLORHAM PARK, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and...

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

FLORHAM PARK, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and...

Form EFFECT - Notice of Effectiveness

Form 8-K - Current report

Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months

56.4% major response rate exceeded 20% primary endpoint 98.2% disease control rate achieved in heavily pretreated patients Responses shown in difficult-to-treat, high-needs patient populations...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALZNAlzamend Neuro Inc	$ 8.3201 (307.87%)	19.86M
VRAXVirax Biolabs Group Ltd	$ 5.18 (143.19%)	32.85M
APDNApplied DNA Sciences Inc	$ 1.42 (81.38%)	50.41M
SONDSonder Holdings Inc	$ 4.09 (56.11%)	2.87M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.6301 (40.84%)	65.14M
LQDALiquidia Corporation	$ 8.90 (-36.92%)	2.64M
JFU9F Inc	$ 1.44 (-23.20%)	1.23k
CINGCingulate Inc	$ 13.935 (-21.23%)	3.23M
YJYunji Inc	$ 0.605 (-20.38%)	13.52k
FFIEFaraday Future Intelligent Electric Inc	$ 4.165 (-18.91%)	539.72k
MAXNMaxeon Solar Technologies Ltd	$ 0.1633 (40.41%)	65.42M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.6301 (40.84%)	65.14M
APDNApplied DNA Sciences Inc	$ 1.42 (81.38%)	50.41M
VRAXVirax Biolabs Group Ltd	$ 5.18 (143.19%)	32.84M
NVDANVIDIA Corporation	$ 124.39 (-0.15%)	21.83M

ALDRADJKD123

ALDRADJKD123 5 minutes ago

Well, here she is…..

https://youtu.be/WS1gI1_UdTo?si=W8XZLOzs11TFUdbd

Debunkinator

Debunkinator 5 minutes ago

Not a good time to bid sit. Just saying. ;)

Triple nickle

Triple nickle 5 minutes ago

Maxthedog

Maxthedog 5 minutes ago

m/wilson

m/wilson 5 minutes ago

Disease resistant and 24 month production.
What’s not to like?

Argeoz

Argeoz 5 minutes ago

Nothing false, it’s now public information via the companies X post, there is some kind of agreement happening.

Triple nickle

Triple nickle 5 minutes ago

peanutz

peanutz 5 minutes ago

Ask is so thin . This is ready with a few slaps . .004 can come quickly!

ExtremelyBullishZig

ExtremelyBullishZig 5 minutes ago

I have 2 items on my news feed.

- Mixed shelf of offering up to 500 million

- And Nikola enters into 160 million dollar securities purchase agreement for senior convertible notes. 80 Million dollar sale to take place Aug. 19.

fink

fink 6 minutes ago

Dropping my kid off in Prague next Monday to study abroad till Dec. wife and I'll take a slide through Eurotrash for 10 days. I'll be broke as chit and be lucky to get another 200k shares.

I'll direct all my other gains into more IGPK over the next 6 months anyways.

learningcurve2020

learningcurve2020 6 minutes ago

Well, we all know there's the Book of Flopper, so full of tall tales.

Monksdream

Monksdream 6 minutes ago

Jwizzz

Jwizzz 6 minutes ago

Everything has changed in 1 week

Chiron

Chiron 6 minutes ago

Terrible interview, rebuy at .002

Major Profits

Major Profits 6 minutes ago

I guess it's a "Wait and see, and HOPE" thing.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174942241

GLTA

AugustaFriends

AugustaFriends 6 minutes ago

Money hunt

Money hunt 6 minutes ago

Boooom blast$$$$$

ALDRADJKD123

ALDRADJKD123 6 minutes ago

People Are Realizing,

https://youtu.be/Ci-QydutFkk?si=-Rs9JnfeSEhZQk8T

Chiron

Chiron 6 minutes ago

cottonmather

cottonmather 6 minutes ago

Andy Schectman. Metal prices. 9 minutes https://youtu.be/lXh75Aiq2F0?si=7THtsGZIJVG5JuRy

Heisgreater

Heisgreater 6 minutes ago

Great PR this morning our game changing ROBUST WORMS will be the most sought after in the industry just give it a bit more time and then BAM!!!
GO KBLB!!!
Kong wanna be

DocKB

DocKB 6 minutes ago

And some get fast-tracked:
BioAtlas Ozuriftamab Vedotin Receives FDA Fast-Track Designation; Shares Rise
9:38 AM ET 7/23/24 | MT Newswires
BioAtla's Ozuriftamab Vedotin Receives FDA Fast-Track Designation; Shares Rise
09:38 AM EDT, 07/23/2024 (MT Newswires) -- BioAtla (BC

TheFinalCD

TheFinalCD 6 minutes ago

Triple nickle

Triple nickle 6 minutes ago

ALZN boom 11.00

redwagon

redwagon 7 minutes ago

Now we wait for Barrett to post the Q report. I don’t see it happening, based on vast amounts of history, before late this evening.

Amundi Asset Management ...

Delayed Upgrade Clock